3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
34
Neoplasm Metastasis
5
Breast Neoplasms
4
Prostate Carcinoma Metastatic to the Bone
2
Multiple Myeloma
2
Metastatic Castration-resistant Prostate Cancer
2
Hormone Refractory Prostate Cancer
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Prostate Cancer Metastatic to Bone
1
Prostate Adenocarcinoma
1
Neoplasms
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Castrate-Resistant Prostate Cancer
1
Bone Metastatic Castration-resistant Prostate Cancer
1
Bone Metastases
1
Bone Diseases
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
enzalutamide
6
Abiraterone Acetate
6
olaparib
5
Docetaxel
5
darolutamide
4
Prednisone
4
Pluvicto
4
cabazitaxel
3
testosterone 17 beta-cypionate
2
radium Ra 223 dichloride
2
fludarabine
2
abiraterone
2
Prednisolone
2
Nivolumab
2
Cyclophosphamide
2
Androgen Antagonists
2
sipuleucel-T
1
rucaparib
1
poly ICLC
1
pamiparib
1
lactitol
1
fludarabine phosphate
1
fluciclovine F-18
1
enfortumab vedotin
1
ebastine
1
copanlisib
1
cabozantinib
1
bempegaldesleukin
1
avelumab
1
alovudine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Metastatic Castration-resistant Prostate Cancer
×
radium Ra 223 dichloride
×
Clear all
NCT04109729
2026-06-01
Rad2Nivo
University of Utah
Phase 1
Active not recruiting
39 enrolled
NCT04237584
2022-10-07
ESCALATE
MANA RBM
Phase 3
Terminated
23 enrolled
11 charts